Anavex Life Sciences Corp (AVXL)

[nidan7500]

Classic problem solving tree shaping up here.

So with the goal of the exercise is to increase the homogeneity of the study population and avoids the noise

The obvious contradiction here. How to increase mix w/o compromising/losing the path to a simple solution? Eventually, we will get to understand how to deal w/this. Or not. A2-73 will probably not always be a one size fits all solution, depending on the criteria for acceptance. I think that is where he is going here.

No mention of the gut microbiome

Agree w/this point and think we all intuit that (at some point on the discovery path) unique DNA, what we eat and much more are certain to be factors in efficacy of any A2-73 treatment. That is where CNS AI precision medicine will have a custom bio-CNS-treatment for every patient.

The good news is, it is becoming more obvious every day that this is finally the right path to CNS wellness. We might ask, how long before AVXL will be snatched by others w/big money who will finish the job. That, and not when do trials start, is our question. Will that happen before/after the big AD paper delivery? Actually, A2-73 trials should be all conducted on the dunes at Kitty Hawk. This is CNS history in the making.